Current operations are generating profit. Cash positive last quarter. The heavy expenses are from expansion activity, most of which will pay for itself within a year of beginning sales. The BarX mortgage debt has about 18 months left on the term and they may pay it off early after the fall harvest.
Mendo cost about $5M and is doing close to 1M/qtr now so they're already near breakeven on the deal. But they just signed an offtake agreement with Triangle for 25% of their harvest for the next 2 years. So they'll have somewhere around 20M worth of product to distribute wholesale. That will pay for itself probably by July.
Bophelo cost 4.5M and they've maybe spent 5-8M so far to build it out. They are anticipated to have revs greater than 25M within a year.
What is your concern, exactly? It's not like they threw our shares away. They got some nice assets for them. I estimate Halo will achieve a 500-800M market cap in short term, and a 5-10B market cap in the long term. So we're talking 300-500% gains probably this year, and 3000-6000% gains in 5 years. Let's say they dilute more to 4B shares without adding revenue and it cuts those percentages in half. That's still a great return.
Of course, anything could happen. I'm not telling anyone to buy. I'm just saying don't be discouraged by nebulous things like dilution because when the revenues start hitting, the turnaround will be swift and dramatic.
